نتائج البحث

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.

• Authors : Sculier, J-P; Lafitte, J-J; Paesmans, M

• Source: British Journal of Cancer. 11/1/2000, Vol. 83 Issue 9, p1128. 8p.

تفاصيل العنوان

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia.

• Authors : Nobbenhuis, M A E; Meijer, C J L M; Brule, A J C van den

• Source: British Journal of Cancer. 3/15/2001, Vol. 84 Issue 6, p796. 6p.

تفاصيل العنوان

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.

• Authors : Rapley, E A; Barfoot, R; Bonaïti-Pellié, C

• Source: British Journal of Cancer. 7/15/2000, Vol. 83 Issue 2, p177. 7p.

تفاصيل العنوان

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients

• Authors : Marjorie C. Green; James L. Murray; Gabriel N. Hortobagyi

Subjects: Adult; Cancer Research; Pathology

• Source: British Journal of Cancer

تفاصيل العنوان

A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours

• Authors : C.M.L. van Herpen; Ingrid M.E. Desar; E A Bone ...

Subjects: Adult; Male; Cancer Research

• Source: British Journal of CancerBritish Journal of Cancer, 103(9), 1362-1368. Nature Publishing GroupBritish

تفاصيل العنوان

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer

• Authors : Marianne Paesmans; Paul Mommen; Jacqueline Schmerber

Subjects: Adult; Male; Cancer Research

• Source: British Journal of Cancer

تفاصيل العنوان

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia

• Authors : Elle K.J. Risse; René H.M. Verheijen; Theo J.M. Helmerhorst ...

Subjects: Adult; Cancer Research; medicine.medical_specialty

• Source: British Journal of CancerBritish Journal of Cancer, 84, 796-801. Nature Publishing Group

تفاصيل العنوان

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients.

• Authors : Cheng YC; Division of Neoplastic Diseases and Related Disorders, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.; Valero V

Subjects: Genes, erbB-2*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

• Source: British journal of cancer [Br J Cancer] 2010 Oct 26; Vol. 103 (9), pp. 1331-4. Date of Electronic Publication: 2010 Sep 28.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours.

• Authors : van Herpen CM; Department of Medical Oncology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands. ; Eskens FA

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Glycine/Glycine/Glycine/*analogs & derivatives ; Hydroxamic Acids/Hydroxamic Acids/Hydroxamic Acids/*administration & dosage

• Source: British journal of cancer [Br J Cancer] 2010 Oct 26; Vol. 103 (9), pp. 1362-8. Date of Electronic Publication: 2010 Sep 28.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer.

• Authors : Lim, S H¹; Kim, T W²; Hong, Y S²

• Source: British Journal of Cancer. 11/17/2015, Vol. 113 Issue 10, p1421-1426. 6p. 1 Diagram, 3 Charts, 1 Graph.

تفاصيل العنوان